Free Trial

Phreesia (NYSE:PHR) General Counsel Allison C. Hoffman Sells 3,133 Shares

Phreesia logo with Medical background

Key Points

  • Allison Hoffman, General Counsel of Phreesia, sold 3,133 shares of the company's stock valued at $72,936.24, reducing her ownership by 2.20%.
  • Phreesia reported a $0.01 EPS for the last quarter, exceeding expectations and showing a 14.9% increase in revenue year-over-year.
  • Recent analyst ratings reflect a positive outlook, with a consensus price target of $34.08 and multiple firms assigning a "buy" or "overweight" rating.
  • Five stocks to consider instead of Phreesia.

Phreesia, Inc. (NYSE:PHR - Get Free Report) General Counsel Allison C. Hoffman sold 3,133 shares of Phreesia stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total transaction of $72,936.24. Following the completion of the sale, the general counsel owned 139,037 shares of the company's stock, valued at approximately $3,236,781.36. The trade was a 2.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Phreesia Price Performance

PHR traded up $0.87 on Monday, hitting $24.74. 1,065,169 shares of the stock were exchanged, compared to its average volume of 1,230,749. The business has a 50-day moving average of $27.51 and a two-hundred day moving average of $26.40. The firm has a market capitalization of $1.48 billion, a price-to-earnings ratio of -58.90 and a beta of 0.72. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.12 and a quick ratio of 2.12. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $32.76.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings results on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.08. Phreesia had a negative net margin of 5.35% and a negative return on equity of 8.75%. The business had revenue of $117.26 million for the quarter, compared to analyst estimates of $116.39 million. During the same quarter last year, the business posted ($0.03) EPS. The firm's revenue for the quarter was up 14.9% on a year-over-year basis. Phreesia has set its FY 2026 guidance at EPS. Sell-side analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on PHR. Needham & Company LLC upped their price target on Phreesia from $29.00 to $35.00 and gave the company a "buy" rating in a research report on Friday, September 5th. Raymond James Financial set a $33.00 target price on Phreesia and gave the company an "outperform" rating in a report on Friday, September 5th. Citigroup restated an "outperform" rating on shares of Phreesia in a report on Monday, September 8th. KeyCorp boosted their price target on shares of Phreesia from $28.00 to $35.00 and gave the stock an "overweight" rating in a research report on Monday, July 14th. Finally, Stephens reiterated an "overweight" rating and set a $32.00 price objective on shares of Phreesia in a research report on Wednesday, September 3rd. One analyst has rated the stock with a Strong Buy rating and twelve have assigned a Buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $34.08.

View Our Latest Stock Report on Phreesia

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in PHR. Cubist Systematic Strategies LLC purchased a new stake in shares of Phreesia during the first quarter valued at approximately $774,000. Principal Financial Group Inc. purchased a new position in shares of Phreesia in the 1st quarter worth about $1,623,000. Deutsche Bank AG grew its position in Phreesia by 95.9% during the fourth quarter. Deutsche Bank AG now owns 57,297 shares of the company's stock valued at $1,442,000 after buying an additional 28,047 shares during the period. Acadian Asset Management LLC increased its holdings in Phreesia by 105.2% during the first quarter. Acadian Asset Management LLC now owns 225,317 shares of the company's stock worth $5,754,000 after buying an additional 115,527 shares during the last quarter. Finally, Bessemer Group Inc. increased its holdings in Phreesia by 23.2% during the first quarter. Bessemer Group Inc. now owns 47,758 shares of the company's stock worth $1,222,000 after buying an additional 8,978 shares during the last quarter. 92.10% of the stock is owned by institutional investors.

About Phreesia

(Get Free Report)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

Featured Stories

Insider Buying and Selling by Quarter for Phreesia (NYSE:PHR)

Should You Invest $1,000 in Phreesia Right Now?

Before you consider Phreesia, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list.

While Phreesia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.